New algorithm aims to prevent organ rejection in kids
NCT ID NCT07549230
First seen Apr 25, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study will develop a computer tool to help doctors give the right dose of tacrolimus to children after a kidney transplant. Tacrolimus is a medicine that prevents the body from rejecting the new kidney, but finding the correct dose can be tricky. The tool uses patient data and machine learning to personalize dosing, aiming to reduce the risk of rejection. The study will include 130 children who are receiving a kidney transplant for the first time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEDIATRIC KIDNEY TRANSPLANTATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.